Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1486
| Despition | VEGF C Rat Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1376 | Mouse S100A5 Protein (AC1376) | 5 µg | inquiry |
| ACPP-1087 | Recombinant Human IL-6 Protein (Fc Chimera 6xHis Tag) (AC1087) | 50 µg | inquiry |
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
| ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1526 | Human KCTD11 Protein (AC1526) | 2 µg | inquiry |
| ACPP-1072 | Synaptophysin Blocking Peptide (AC1072) | 250 µg | inquiry |
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.